CRISPR Therapeutics AG - CRSP - stock price prediction, stock price target, analyst ratings from 28 analysts
CRISPR Therapeutics AG has a share price target of US$ 83, revenue growth forecast of 58.9%, and profit growth estimate of -12.2% for FY25, based on top 28 analyst calls.